1.
Knörr F, Zimmermann M, Attarbaschi A, Kabíčková E, Maecker-Kolhoff B, Ruf S, Kühnle I, Ebinger M, Garthe A-K, Simonitsch-Klupp I, Oschlies I, Klapper W, Burkhardt B, Woessmann W. Dose-adjusted EPOCH-rituximab or intensified B-NHL therapy for pediatric primary mediastinal large B-cell lymphoma. haematol [Internet]. 2021Dec.1 [cited 2024Apr.20];106(12):3232-5. Available from: https://haematologica.org/article/view/haematol.2021.278971